| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75d4c933147ea96ce936835c056725ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_173bc2c63b34988699010ba05e5b1376 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8253 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2001-01-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3c12a15700197a23cb40c4b2f855606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_042a097bbb78dbaa3bbd6b0bc52aec91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfa41deed93530db046d27bb4cd76af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a74e8d7b90dc8908d3f22d1202f456e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8908c03766fcafebea9ceee32baa4e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b6ccc349d639129d4d3f324133a46e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0baf5d339b45cf1df73c854eabea33df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a638acd73fcbd74ac14ad6365040c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_865ade9d2009b2f9a5690984f73c6b61 |
| publicationDate |
2002-10-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1246906-A2 |
| titleOfInvention |
P450 monooxygenases of the cyp79 family |
| abstract |
The invention provides DNA coding for cytochrome P450 monooxygenases of the CYP79 family catalyzing the conversion of an aliphatic or aromatic acid or chain-elongated methionine homologue to the corresponding oxime. Preferred embodiments of the invention are enzymes catalyzing the conversion of L-Valine and L-Isoleucine such as the cassava enzymes CYP79D1 and CYP79D2, enzymes catalyzing the conversion of tyrosine such as the Triglochin maritima enzymes CYP79E1 and CYP79E2, enzymes catalyzing the conversion of tryptophan to the corresponding oxime indole-3-acetaldoxine such as the Arabidopsis thaliana enzyme CYP79A2 and the Bassica napus enzyme CYP79B5, and enzymes catalyzing the conversion of a chain-elongated methionine homologue such as the Arabidopsis thaliana enzymes CYP79F1 and CYP79F2. Transgenic expression of said DNA or parts thereof in plants can be used to manipulate the biosynthesis of corresponding glucosinolates or cyanogenic glucosides. |
| priorityDate |
2000-01-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |